US pharma giant Pfizer's combination of nirmatrelvir and ritonavir was the "superior choice" of treatment for unvaccinated, elderly or immu...

The National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of ...

Although Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...

Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...

The SEC asked the companies to conduct bioavailability and bioequivalence (BA/BE) studies and submit safety data at its meeting on Friday, ...

The EMA's review of Merck's pill, developed with Ridgeback Biotherapeutics, is taking longer than Pfizer's because Merck released trial dat...

The approval comes as the country scrambles to build its defences amid a record hit a daily record of new COVID-19 cases on Thursday, gover...

You'll need a prescription first from a doctor or other authorized health worker.

The U.S. recently added two new weapons to its small arsenal against the coronavirus: pills that patients can take at home to treat COVID-1...

Merck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30% in a cl...

Data from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in pati...

The Food and Drug Administration is expected to soon rule on whether to authorize Pfizer's pill and a competing pill from Merck, which was ...

The coronavirus is headed to the endemic stage in certain countries, giving these new drugs a potentially huge market, along with the abili...

Pfizer said it will waive royalties on sales in all countries covered by the agreement while COVID-19 remains classified as a Public Health...

The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified ...

Pfizer said it plans to submit interim trial results for its pill, which is given in combination with an older antiviral called ritonavir, ...

The first pill to treat Covid-19 is on its way and vaccine producers are rolling out booster shots in wealthy countries. For investors, the...